1.Heart failure as the first manifestation of renal cell carcinoma.
Chee Meng LEE ; Allen SIM ; Gunasegaran KURUGULASIGAMONEY ; Lay Guat NG
Korean Journal of Urology 2015;56(1):82-85
We report the rare case of a patient with advanced renal cell carcinoma (RCC) who initially presented to the hospital with symptoms of cardiac failure. Preoperative cardiac studies did not reveal any underlying ischemia. After resection of a large 14-cm left renal tumor, cardiac function was noted to improve dramatically. We discuss this case of concomitant RCC and nonischemic cardiomyopathy.
Asian Continental Ancestry Group
;
Carcinoma, Renal Cell/*diagnosis/surgery
;
Cardiomyopathies/*diagnosis
;
Female
;
Heart Failure/*etiology
;
Humans
;
Middle Aged
;
Paraneoplastic Syndromes/complications
;
Thalassemia/complications
2.Aging Male Symptoms Scale (Ams) For Health-Related Quality Of Life In Aging Men: Translation And Adaptation In Malay
Hui Meng Tan ; Wah Yun Low ; Seng Fah Tong ; Jamaiyah Haniff ; Geeta Appannah ; Verna K.M. Lee ; Ee Ming Khoo ; Chirk Jenn Ng ; Christopher Chee Kong Ho
Malaysian Journal of Public Health Medicine 2015;15(2):17-23
The Aging Male Symptoms Scale (AMS) measures health-related quality of life in aging men. The objective of this paper is to describe the translation and validation of the AMS into Bahasa Melayu (BM). The original English version of the AMS was translated into BM by 2 translators to produce BM1 and BM2, and subsequently harmonized to produce BM3. Two other independent translators, blinded to the English version, back-translated BM3 to yield E2 and E3. All versions (BM1, BM2, BM3, E2, E3) were compared with the English version. The BM pre-final version was produced, and pre-tested in 8 participants. Proportion Agreement, Weighted Kappa, Spearman Rank Correlation Coefficient, and verbatim responses were used. The English and the BM versions showed excellent equivalence (weighted Kappa and Spearman Rank Coefficients, ranged from 0.72 to 1.00, and Proportion Agreement values ranged from 75.0% to 100%). In conclusion, the BM version of the AMS was successfully translated and adapted.
3.The role of PIVKA-II in hepatocellular carcinoma surveillance in an Asian population.
Wai Yoong NG ; Daniel Yan Zheng LIM ; Si Yu TAN ; Jason Pik Eu CHANG ; Thinesh Lee KRISHNAMOORTHY ; Chee Hooi LIM ; Damien Meng Yew TAN ; Victoria Sze Min EKSTROM ; George Boon Bee GOH ; Mark Chang Chuen CHEAH ; Rajneesh KUMAR ; Chin Pin YEO ; Chee Kiat TAN
Annals of the Academy of Medicine, Singapore 2023;52(2):108-110
4.Perioperative Outcomes of Therapeutic Breast Surgery in the Elderly.
Chee Meng LEE ; Veronique Km TAN ; Benita Kt TAN ; Preetha MADHUKUMAR ; Wei Sean YONG ; Chow Yin WONG ; Kong Wee ONG
Annals of the Academy of Medicine, Singapore 2016;45(6):261-263
Aged, 80 and over
;
Axilla
;
Breast Neoplasms
;
epidemiology
;
surgery
;
Comorbidity
;
Diabetes Mellitus
;
epidemiology
;
Dyslipidemias
;
epidemiology
;
Female
;
Humans
;
Hypertension
;
epidemiology
;
Length of Stay
;
Lymph Node Excision
;
Mastectomy
;
Myocardial Infarction
;
epidemiology
;
Myocardial Ischemia
;
epidemiology
;
Operative Time
;
Postoperative Complications
;
epidemiology
;
Postoperative Hemorrhage
;
epidemiology
;
Seroma
;
epidemiology
;
Singapore
;
epidemiology
;
Surgical Wound Dehiscence
;
epidemiology
;
Surgical Wound Infection
;
epidemiology
;
Venous Thrombosis
;
epidemiology
5.Academy of Medicine-Ministry of Health clinical practice guidelines: attention deficit hyperactivity disorder.
Daniel S S FUNG ; Choon Guan LIM ; John Chee Meng WONG ; Koon Hock NG ; Christopher Cheng Soon CHEOK ; Jennifer Sie Hee KIING ; Shang Chee CHONG ; June LOU ; Mary Lourdes DANIEL ; Desmond ONG ; Charity LOW ; Sharifah Mariam ALJUNIED ; Pui Meng CHOI ; Kala MEHROTRA ; Carolyn KEE ; Ivy LEUNG ; Lee Chen YEN ; Geraldine WONG ; Poh Yin LEE ; Bella CHIN ; Hwee Chien NG
Singapore medical journal 2014;55(8):411-quiz 415
The Academy of Medicine (AMS) and the Ministry of Health (MOH) have developed the clinical practice guidelines on Attention Deficit Hyperactivity Disorder (ADHD) to provide doctors and patients in Singapore with evidence-based treatment for ADHD. This article reproduces the introduction and executive summary (with recommendations from the guidelines) from the MOH clinical practice guidelines on ADHD, for the information of SMJ readers. Chapters and page numbers mentioned in the reproduced extract refer to the full text of the guidelines, which are available from the Ministry of Health website: http://www.moh.gov.sg/content/moh_web/healthprofessionalsportal/doctors/guidelines/cpg_medical.html.The recommendations should be used with reference to the full text of the guidelines. Following this article are multiple choice questions based on the full text of the guidelines.
Attention Deficit Disorder with Hyperactivity
;
diagnosis
;
drug therapy
;
therapy
;
Caregivers
;
Child
;
Evidence-Based Medicine
;
Humans
;
Methylphenidate
;
therapeutic use
;
Parents
;
Psychiatry
;
methods
;
standards
;
Singapore
;
Societies, Medical
6.Singapore Defibrillation Guidelines 2016.
Chun Yue Francis LEE ; Venkataraman ANANTHARAMAN ; Swee Han LIM ; Yih Yng NG ; Tek Siong CHEE ; Chong Meng SEET ; Marcus Eng Hock ONG
Singapore medical journal 2017;58(7):354-359
The most common initial rhythm in a sudden cardiac arrest is ventricular fibrillation or pulseless ventricular tachycardia. This is potentially treatable with defibrillation, especially if provided early. However, any delay in defibrillation will result in a decline in survival. Defibrillation requires coordination with the cardiopulmonary resuscitation component for effective resuscitation. These two components, which form the key links in the chain of survival, have to be brought to the cardiac victim in a timely fashion. An effective chain of survival is needed in both the institution and community settings.
7.Treatment and outcomes of high-risk neuroblastoma in Southeast Asia: a single-institution experience and review of the literature.
Anselm Chi-Wai LEE ; Chan Hon CHUI ; Robert KWOK ; Kim Shang LEE ; Chee Meng FONG ; Wilfred Hing-Sang WONG
Singapore medical journal 2023;64(5):319-325
INTRODUCTION:
In Europe and North America, the majority of children with high-risk neuroblastoma survive the disease. Elsewhere, the treatment outcomes are poor.
METHODS:
A retrospective review of children treated for high-risk neuroblastoma in a single institution in Singapore from 2007 to 2019 was carried out. Treatment consisted of intensive chemotherapy, surgery aimed at gross total resection of residual disease after chemotherapy, consolidation with high-dose therapy followed by autologous stem cell rescue, and radiotherapy to the primary and metastatic sites followed by maintenance treatment with either cis-retinoic acid or anti-disialoganglioside monoclonal antibody therapy. Survival data were examined on certain clinical and laboratory factors.
RESULTS:
There were 57 children (32 male) treated for high-risk neuroblastoma. Their mean age was 3.9 (range 0.7-14.9) years. The median follow-up time was 5.5 (range 1.8-13.0) years for the surviving patients. There were 31 survivors, with 27 patients surviving in first remission, and the five-year overall survival and event-free survival rates were 52.5% and 47.4%, respectively. On log-rank testing, only the group of 17 patients who were exclusively treated at our centre had a survival advantage. Their five-year overall survival rate compared to patients whose initial chemotherapy was done elsewhere was 81.6% versus 41.1% (P = 0.011), and that of event-free survival was 69.7% versus 36.1% (P = 0.032). Published treatment results were obtained from four countries in Southeast Asia with five-year overall survival rates from 13.5% to 28.2%.
CONCLUSION
Intensified medical and surgical treatment for high-risk neuroblastoma proved to be effective, with superior survival rates compared to previous data from Southeast Asia.
Child
;
Humans
;
Male
;
Infant
;
Child, Preschool
;
Adolescent
;
Disease-Free Survival
;
Neuroblastoma/pathology*
;
Hematopoietic Stem Cell Transplantation/methods*
;
Treatment Outcome
;
Antineoplastic Combined Chemotherapy Protocols/therapeutic use*
;
Asia, Southeastern/epidemiology*
;
Combined Modality Therapy